Jared S. Hopkins

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Starboard said a former CEO and CFO had assisted in its activist campaign but then were pressured to express support for the drugmaker.

With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to new heights in the pandemic

Tactile displays on devices could help level the playing field for students and one day even show moving images and live sports

The pharmaceutical company reported its third consecutive quarter with positive results.

The pharmaceutical company reported its third consecutive quarter with positive results.

The pharmaceutical company raised its revenue outlook for the year to between $61 billion to $64 billion, up from $59.5 billion to $62.5 billion previously.

U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as geopolitical tensions rise.

U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as geopolitical tensions rise.

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients.